Skip to main content

Table 2 Demographics

From: Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography

Syndromic diagnosis CBS-PIB + (number = 11) CBS-PIB - (number = 14) NC (number = 26) P Post hoc
Age at PET 66.9 ± 5.5 65.8 ± 8.8 70.2 ± 2.9 0.054  
Age at MRI 67.2 ± 5.2 66.1 ± 9.3 (n = 13)   0.110  
Age at first clinic visit 65.6 ± 9.1 66.5 ± 5.1 n/a 0.750  
Male: Female 6:5 6:8 14:12 0.810  
Education, years 15.7 ± 2.2 15.8 ± 2.4 17.3 ± 2.0 0.620  
MMSE 22.9 ± 6.3 22.4 ± 6.9 29.2 ± 1.2 0.0001 CBS-PIB+ vs NC P <0.05,
CBS-PIB- vs NC P <0.01
CDR 0.7 ± 0.5 0.9 ± 0.6 n/a 0.830  
CDR-SB 4.7 ± 3.2 3.7 ± 2.6 n/a 0.400  
APOE4 (0,1,2) 4, 6, 0 (n = 10) 9, 1, 0 (n = 10) 17, 8, 1 0.066 CBS-PIB+ vs CBS-PIB- P < 0.05
  1. CBS-PIB+, Corticobasal syndrome positive for Pittsburgh compound B; CBS-PIB-, Corticobasal syndrome negative for Pittsburgh compound B; CDR, Clinical Dementia Rating; CDR-SB, Clinical Dementia Rating sum of boxes; MMSE, Mini-mental State Examination; n/a, not applicable; NC, normal control. Data are mean ± standard deviation.